ANYO Labs

ANYO Labs is an early drug discovery company with a novel patent pending artificial intelligence scoring method unlike any other on the market. With the help of molecular biology scientists and professor, this unique method allows for extreme data and energy efficient ways of finding drug compounds for further testing in the lab and clinical trials. 

The market potential is very large and is targeted towards chemisty research facilities as well as small and big pharmacauticul institutions. 

We have incorporated in december 2022, secured funding from Chalmers Ventures, have validated our technolgy through benchmarks, case studies, customer interviews, a pilot project, and are in discussion with a research facility as well as a global pharmaceutical company about further projects and further collaboration. We have also recently filed for a patent. We are now looking into synthesising our own compounds and compare them to our predicted parameters to validate our technology even further.